UTAH MEDICAL PRODUCTS, INC. Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
UTAH MEDICAL PRODUCTS, INC. (UTMD) reported Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense of $4.00 thousand for the 12-month period ending 2020-12-31, per its 10-K/A filed 2023-03-28.
Discontinued › Expense Statement › Interest Expense
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense · last filed 2023-03-28
- UTAH MEDICAL PRODUCTS, INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2020 was $4.00K.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month |
|---|---|
| 2020-12-31 | $4.00K 10-K/A · filed 2023-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |